MedTrace Logo

Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System

NCT04807283 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2023-10-03

No results posted yet for this study

Summary

The objective of this study is to demonstrate safety and effectiveness using a percutaneous Delivery System of the Laminar Left Atrial Appendage Closure System to treat patients with NVAF to reduce the risk of thromboembolism from the left atrial appendage (LAA).

Conditions

Interventions

DEVICE

Left Atrial Appendage Closure

Closure or occlusion of the left atrial appendage to reduce the risk of thromboembolism in patients with NVAF

Sponsors & Collaborators

  • Laminar, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-05
Primary Completion
2021-11-26
Completion
2023-12-31
FDA Device
Yes

Countries

  • Georgia
  • Paraguay

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04807283 on ClinicalTrials.gov